scispace - formally typeset
C

Carmen Urbich

Researcher at Goethe University Frankfurt

Publications -  96
Citations -  25642

Carmen Urbich is an academic researcher from Goethe University Frankfurt. The author has contributed to research in topics: Endothelial stem cell & Progenitor cell. The author has an hindex of 60, co-authored 96 publications receiving 24660 citations.

Papers
More filters
Journal ArticleDOI

Endothelial Progenitor Cells: Characterization and Role in Vascular Biology

TL;DR: This review summarizes the mechanisms regulating endothelial progenitor cell–mediated neovascularization and reendothelialization and describes the characterization of the different progenitors cell populations.
Journal ArticleDOI

Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease

TL;DR: Patients with CAD revealed reduced levels and functional impairment of EPCs, which correlated with risk factors for CAD, and hypertension was identified as a major independent predictor for impaired EPC migration.
Journal ArticleDOI

Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

TL;DR: In patients with AMI, intracoronary infusion of autologous progenitor cells appears to be feasible and safe and may beneficially affect postinfarction remodeling processes.
Journal ArticleDOI

Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells.

TL;DR: It is indicated that eNOS expressed by bone marrow stromal cells influences recruitment of stem and progenitor cells, which may contribute to impaired regeneration processes in ischemic heart disease patients, who are characterized by a reduced systemic NO bioactivity.
Journal ArticleDOI

MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice

TL;DR: It is shown that themiR-17~92 cluster is highly expressed in human endothelial cells and that miR-92a, a component of this cluster, controls the growth of new blood vessels (angiogenesis) and may serve as a valuable therapeutic target in the setting of ischemic disease.